7/104 sources · 2 publishersUpdated Nov 6, 21:44 UTC
Omada Health posts Q3 profit, raises 2026 guidance and announces CEO transition
Omada Health reported a net profit of $6.55 million for Q3 2026, driven by revenue of $91.31 million and adjusted EBITDA of $12.38 million. The company lifted its full‑year 2026 revenue outlook to $344 million‑$346 million and adjusted EBITDA to $32 million‑$34 million. It also disclosed that Wei‑Li Shao will become CEO on January 1 2027, with current CEO Sean Duffy moving to executive chair.
Why it matters
The profit and higher guidance suggest stronger financial performance, but the stock fell 20.37% on the news, indicating market concern that may affect short‑term investor sentiment.
Key facts
- 1Q3 2026 net income was $6.55 million, or $0.11 per share, compared with a loss of $3.18 million in the same quarter of 2025. rttnews.com
- 2Revenue for the quarter was $91.31 million, up from $68.03 million a year earlier. rttnews.com
- 3Adjusted EBITDA for Q3 2026 was $12.38 million, versus $2.38 million in 2025. rttnews.com
- 4Cash and cash equivalents at September 30 2026 totaled $243.15 million. rttnews.com
- 5Total members reached 1.1 million, a 36% year‑over‑year increase. finance.yahoo.com
- 6Average member tenure grew to approximately 2 years and 4 months, a >10% increase YoY. rttnews.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.